Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort
- 1 November 2003
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (17) , 2521-2527
- https://doi.org/10.1097/00002030-200311210-00016
Abstract
Objective: To describe the demographics, risk behaviors, and HIV-1 subtypes in a large cohort of recently HIV-infected military personnel. Design: Descriptive, cross-sectional study. Methods: US military personnel with recent HIV seroconversion from six medical referral centers were enrolled with a self-administered questionnaire, CD4 cell counts, syphilis and hepatitis B serologies, plasma viral RNA levels, and HIV-1 subtype nucleic acid sequencing. Results: Between February 1997 and May 2000, 520 patients were enrolled. Most [488 (94.3%)] were infected with HIV-1 subtype B. The most prevalent non-B subtype was a circulating recombinant form (CRF01_AE) [17 (61%)]; however, two pure subtypes (C and D), as well as CRF02_AG, CRF09_cpx and a BE recombinant were identified. The likely area of HIV-1 acquisition was the United States for 70% of the volunteers. At least three non-B subtype infections (two subtype C, one subtype CRF01_AE) were apparently acquired domestically. Risk behaviors and comorbid sexually transmitted diseases were reported during the seroconversion period. Volunteers with non-B subtype HIV infection were more likely to report heterosexual contacts [92% vs. 39%; odds ratio (OR), 10.0], including contacts with commercial sex workers (41% vs. 13%; OR, 4.9). The Roche Amplicor version 1.0 assay was less sensitive for non-B subtype infections than the Roche Amplicor version 1.5 assay. Conclusion: There is a high prevalence and diversity of non-B HIV subtypes in this large cohort. Efficient diagnosis of acute primary HIV-1 infection was identified as a goal for prevention programs. Modifiable risk behaviors and target populations for intervention were identified.Keywords
This publication has 24 references indexed in Scilit:
- Evaluation of United States-Licensed Human Immunodeficiency Virus Immunoassays for Detection of Group M Viral VariantsJournal of Clinical Microbiology, 2001
- Diagnosis of Human Immunodeficiency Virus Type 1 Infection with Different Subtypes Using Rapid TestsClinical and Diagnostic Laboratory Immunology, 2000
- Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnelAIDS, 2000
- Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1New England Journal of Medicine, 2000
- Human Immunodeficiency Virus (HIV) Subtype Surveillance of African‐Born Persons at Risk for Group O and Group N HIV Infections in the United StatesThe Journal of Infectious Diseases, 2000
- Presence of Human Immunodeficiency Virus (HIV) Type 1, Group M, Non‐B Subtypes, Bronx, New York: A Sentinel Site for Monitoring HIV Genetic Diversity in the United StatesThe Journal of Infectious Diseases, 2000
- Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapyAIDS, 2000
- Drug Resistance Patterns, Genetic Subtypes, Clinical Features, and Risk Factors in Military Personnel with HIV-1 SeroconversionAnnals of Internal Medicine, 1999
- Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 regionAIDS, 1999
- Acute primary HIV infectionPublished by American Medical Association (AMA) ,1997